ORBIMED ADVISORS LLC Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for February 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 34.80 | 809,614 | 28,174,567 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 34.80 | 1,428,553 | 49,713,644 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 46.56 | 18,810,000 | 875,793,600 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Option Exercise | D | 46.56 | 33,190,000 | 1,545,326,400 | 0 | |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | P | 7.20 | 342,132 | 2,463,350 | 3,316,128 | 3 M to 3.3 M (+11.50 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Buy | P | 7.20 | 603,687 | 4,346,546 | 5,890,884 | 5.3 M to 5.9 M (+11.42 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Grant | A | 7.20 | 2,905,396 | 20,918,851 | 2,973,996 | 68.6 K to 3 M (+4,235.27 %) |
Feb 23 2018 | XTNT | Xtant Medical Hold ... | ORBIMED ADVISORS LLC | Director | Grant | A | 7.20 | 5,126,534 | 36,911,045 | 5,287,197 | 160.7 K to 5.3 M (+3,190.86 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.08 | 17 | 86 | 0 | |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.08 | 1,765 | 8,966 | 0 | |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 4.68 | 58 | 271 | 0 | |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 4.68 | 6,057 | 28,347 | 0 | |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 8.98 | 75 | 674 | 49,270 | 49.3 K to 49.3 K (-0.15 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 8.98 | 7,822 | 70,242 | 5,500,730 | 5.5 M to 5.5 M (-0.14 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.08 | 17 | 86 | 49,345 | 49.3 K to 49.3 K (+0.03 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.08 | 1,765 | 8,966 | 5,508,552 | 5.5 M to 5.5 M (+0.03 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 4.68 | 58 | 271 | 49,328 | 49.3 K to 49.3 K (+0.12 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 4.68 | 6,057 | 28,347 | 5,506,787 | 5.5 M to 5.5 M (+0.11 %) |
Feb 06 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.73 | 37,840 | 557,383 | 3,422,840 | 3.4 M to 3.4 M (+1.12 %) |
Feb 02 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.99 | 22,840 | 342,372 | 3,385,000 | 3.4 M to 3.4 M (+0.68 %) |
Feb 02 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 15.00 | 339,400 | 5,091,000 | 3,362,160 | 3 M to 3.4 M (+11.23 %) |